KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $5.2 billion.

  • Quest Diagnostics' Non-Current Debt fell 844.55% to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year decrease of 844.55%. This contributed to the annual value of $5.6 billion for FY2024, which is 2732.43% up from last year.
  • As of Q3 2025, Quest Diagnostics' Non-Current Debt stood at $5.2 billion, which was down 844.55% from $5.2 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Non-Current Debt ranged from a high of $5.9 billion in Q1 2025 and a low of $3.8 billion during Q2 2023
  • In the last 5 years, Quest Diagnostics' Non-Current Debt had a median value of $4.0 billion in 2021 and averaged $4.4 billion.
  • Over the last 5 years, Quest Diagnostics' Non-Current Debt had its largest YoY gain of 5399.58% in 2025, and its largest YoY loss of 844.55% in 2025.
  • Quarter analysis of 5 years shows Quest Diagnostics' Non-Current Debt stood at $4.0 billion in 2021, then fell by 0.8% to $4.0 billion in 2022, then rose by 10.86% to $4.4 billion in 2023, then grew by 27.32% to $5.6 billion in 2024, then dropped by 7.91% to $5.2 billion in 2025.
  • Its last three reported values are $5.2 billion in Q3 2025, $5.2 billion for Q2 2025, and $5.9 billion during Q1 2025.